Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Biologics : Targets & Therapy|July 13, 2013
Erythropoiesis stimulating agents: approaches to modulate activityAngus M SinclairBiologics : Targets & Therapy|August 1, 2012
The effect of erythropoietin on normal and neoplastic cellsSteve Elliott, Angus M SinclairJournal of Pharmaceutical Sciences|June 17, 2005
Glycoengineering: the effect of glycosylation on the properties of therapeutic proteinsAngus M Sinclair, Steve ElliottAmerican Journal of Physiology. Renal Physiology|September 10, 2002
Regulation of kidney-specific Ksp-cadherin gene promoter by hepatocyte nuclear factor-1betaYun Bai, Marco Pontoglio, Thomas Hiesberger, et al.Antibodies (Basel, Switzerland)|October 17, 2020
Structure, Function, and Therapeutic Use of IgM AntibodiesBruce A Keyt, Ramesh Baliga, Angus M Sinclair, et al.Experimental Hematology|March 11, 2015
Romiplostim promotes platelet recovery in a mouse model of multicycle chemotherapy-induced thrombocytopeniaPatricia L McElroy, Ping Wei, Keri Buck, et al.Cancer|June 22, 2007
Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patientsAngus M Sinclair, Marque D Todd, Kevin Forsythe, et al.Journal of Biomolecular Screening|December 6, 2014
Characterization of bispecific T-cell Engager (BiTE) antibodies with a high-capacity T-cell dependent cellular cytotoxicity (TDCC) assayAaron A Nazarian, Ivonne L Archibeque, Yen H Nguyen, et al.Proceedings of the National Academy of Sciences of the United States of America|April 4, 2003
Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney diseaseFangming Lin, Thomas Hiesberger, Kimberly Cordes, et al.The Journal of Clinical Investigation|April 7, 2004
Mutation of hepatocyte nuclear factor-1beta inhibits Pkhd1 gene expression and produces renal cysts in miceThomas Hiesberger, Yun Bai, Xinli Shao, et al.Pageof 3